CD19 and infection: The present data suggest that LGG administration may promote early immunity to S. 4,[5],12:i:- infection by inducing the expansion of CD3-CD19-T-bet+IFNγ+ and CD3-CD19-T-bet+IFNγ- cell subsets in the peripheral blood.